| |
| |
|
| Insider
Information: |
Aldrich Richard |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
444,838 |
|
|
Indirect Shares
|
12,959,539 |
|
|
| Direct
Value |
$1,394,222 |
|
|
|
Indirect Value
|
$84,759,662 |
|
|
| Total
Shares |
13,404,377 |
|
|
| Total
Value |
$86,153,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 81.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
2006-01-25 |
30,527 |
|
0 |
Premium* |
|
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2006-12-21 |
0 |
2006-12-21 |
3,662,662 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
2008-06-06 |
0 |
2008-06-25 |
5,853,697 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-29 |
0 |
2008-10-29 |
1,081,410 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-10-30 |
0 |
2008-11-14 |
697,309 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2014-05-20 |
408,142 |
2014-05-20 |
299,294 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
6,169 |
2018-12-07 |
130,683 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
Director |
2015-06-08 |
0 |
2013-06-25 |
300,000 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2023-03-06 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2016-11-21 |
0 |
2017-10-12 |
934,484 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-08-26 |
4 |
AB |
$14.21 |
$14,210 |
I/I |
1,000 |
9,000 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-09-03 |
4 |
AB |
$14.07 |
$14,070 |
I/I |
1,000 |
10,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-06-02 |
4 |
AB |
$7.29 |
$14,580 |
I/I |
2,000 |
10,850 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-09-09 |
4 |
AB |
$14.04 |
$14,040 |
I/I |
1,000 |
11,000 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-29 |
4 |
AS |
$21.36 |
$106,800 |
I/I |
(5,000) |
11,946 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-09-16 |
4 |
AB |
$13.81 |
$13,810 |
I/I |
1,000 |
12,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-06-09 |
4 |
AB |
$7.59 |
$15,180 |
I/I |
2,000 |
12,850 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-09-23 |
4 |
AB |
$13.17 |
$13,170 |
I/I |
1,000 |
13,000 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-09-30 |
4 |
AB |
$12.55 |
$12,550 |
I/I |
1,000 |
14,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-12-30 |
4 |
A |
$1.53 |
$10,624 |
D/D |
6,944 |
14,290 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-06-16 |
4 |
AB |
$8.52 |
$17,040 |
I/I |
2,000 |
14,850 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-10-07 |
4 |
AB |
$11.53 |
$11,530 |
I/I |
1,000 |
15,000 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-10-14 |
4 |
AB |
$10.56 |
$10,560 |
I/I |
1,000 |
16,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-06-23 |
4 |
AB |
$8.81 |
$17,627 |
I/I |
2,000 |
16,850 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-26 |
4 |
AS |
$20.46 |
$102,300 |
I/I |
(5,000) |
16,946 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-10-21 |
4 |
AB |
$12.57 |
$12,570 |
I/I |
1,000 |
17,000 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-10-28 |
4 |
AB |
$11.26 |
$11,260 |
I/I |
1,000 |
18,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-06-30 |
4 |
AB |
$9.16 |
$18,320 |
I/I |
2,000 |
18,850 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-11-04 |
4 |
AB |
$10.51 |
$10,510 |
I/I |
1,000 |
19,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-07-07 |
4/A |
AB |
$9.49 |
$9,490 |
I/I |
1,000 |
19,850 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,681 |
19,971 |
0 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2013-11-11 |
4 |
AB |
$10.93 |
$10,930 |
I/I |
1,000 |
20,000 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2014-07-07 |
4 |
AB |
$9.49 |
$18,980 |
I/I |
2,000 |
20,850 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-04-08 |
4 |
B |
$29.97 |
$74,925 |
I/I |
2,500 |
22,350 |
2.1 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,810 |
26,781 |
0 |
- |
|
141 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
